IJMS | Free Full-Text | Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
How does infliximab work in rheumatoid arthritis? | Arthritis Research & Therapy | Full Text
Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?
Development of anti-TNF therapy for rheumatoid arthritis | Nature Reviews Immunology
Current immunotherapy in rheumatoid arthritis | Immunotherapy
IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
Mechanisms of action of anti-TNF biologics. Anti-TNF biologics bind and... | Download Scientific Diagram
Mode of action of anti-TNF agents in rheumatoid macrophages. IL-10,... | Download Scientific Diagram
Infliximab - Wikipedia
GIH Exam 1 Pharmacology - Small and Large Bowel Drugs (Wallace) Flashcards | Quizlet
A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar | SpringerLink
Emerging Mechanisms of Action and Loss of Response to Infliximab in Ibd: A Broader Picture | Semantic Scholar
The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease
Clinical Benefits of Switching from Original Infliximab to its Biosimilar (CT-P13) as a Potential TNF-α Inhibitor
Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists - ScienceDirect
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Synovial Inflammatory Pathways Characterize Anti‐TNF–Responsive Rheumatoid Arthritis Patients - Wang - 2022 - Arthritis & Rheumatology - Wiley Online Library
Upadacitinib More Effective Than Abatacept for Hard-to-Treat Rheumatoid Arthritis
Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis | Biomarkers in Medicine
Treatment of Rheumatoid Arthritis with Biological Agents | IntechOpen
Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology? | Gut
Emerging Mechanisms of Action and Loss of Response to Infliximab in Ibd: A Broader Picture
JPM | Free Full-Text | Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Frontiers | Targeting TNF-α for COVID-19: Recent Advanced and Controversies
Rheumatoid_Arthritis_Treatments_with_Biologics
